Fragment-based drug discovery has been an effective paradigm in early-stage drug development. An open challenge in this area is designing linkers between disconnected molecular fragments of interest ...
This retrospective study was approved by the Osaka University Clinical Research Review Committee, and the requirement for informed consent was waived by the Osaka University Clinical Research Review ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results